21
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Eradication of P. aeruginosa biofilm in endotracheal tubes based on lock therapy: results from an in vitro study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Despite the several strategies available for the management of biofilm-associated ventilator-associated pneumonia, data regarding the efficacy of applying antibiotics to the subglottic space (SS) are scarce. We created an in vitro model to assess the efficacy of antibiotic lock therapy (ALT) applied in the SS for eradication of Pseudomonas aeruginosa biofilm in endotracheal tubes (ETTs).

          Methods

          We applied 2 h of ALT to a P. aeruginosa biofilm in ETTs using a single dose (SD) and a 5-day therapy model (5D). We used sterile saline lock therapy (SLT) as the positive control. We compared colony count and the percentage of live cells between both models.

          Results

          The median (IQR) cfu counts/ml and percentage of live cells in the SD-ALT and SD-SLT groups were, respectively, 3.12 × 10 5 (9.7 × 10 4-0) vs. 8.16 × 10 7 (7.0 × 10 7-0) ( p = 0.05) and 53.2% (50.9%-57.2%) vs. 91.5% (87.3%-93.9%) ( p < 0.001). The median (IQR) cfu counts/ml and percentage of live cells in the 5D-ALT and 5D-SLT groups were, respectively, 0 (0-0) vs. 3.2 × 10 7 (2.32 × 10 7-0) ( p = 0.03) and 40.6% (36.6%-60.0%) vs. 90.3% (84.8%-93.9%) ( p < 0.001).

          Conclusion

          We demonstrated a statistically significant decrease in the viability of P. aeruginosa biofilm after application of 5D-ALT in the SS. Future clinical studies to assess ALT in patients under mechanical ventilation are needed.

          Related collections

          Most cited references28

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          The importance of the viable but non-culturable state in human bacterial pathogens

          Many bacterial species have been found to exist in a viable but non-culturable (VBNC) state since its discovery in 1982. VBNC cells are characterized by a loss of culturability on routine agar, which impairs their detection by conventional plate count techniques. This leads to an underestimation of total viable cells in environmental or clinical samples, and thus poses a risk to public health. In this review, we present recent findings on the VBNC state of human bacterial pathogens. The characteristics of VBNC cells, including the similarities and differences to viable, culturable cells and dead cells, and different detection methods are discussed. Exposure to various stresses can induce the VBNC state, and VBNC cells may be resuscitated back to culturable cells under suitable stimuli. The conditions that trigger the induction of the VBNC state and resuscitation from it are summarized and the mechanisms underlying these two processes are discussed. Last but not least, the significance of VBNC cells and their potential influence on human health are also reviewed.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial.

            Selective decontamination of the digestive tract (SDD) is an infection-prevention regimen used in critically ill patients. We assessed the effects of SDD on intensive-care-unit (ICU) and hospital mortality, and on the acquisition of resistant bacteria in adult patients admitted to intensive care. We did a prospective, controlled, randomised, unblinded clinical trial. 934 patients admitted to a surgical and medical ICU were randomly assigned oral and enteral polymyxin E, tobramycin, and amphotericin B combined with an initial 4-day course of intravenous cefotaxime (SDD group n=466), or standard treatment (controls n=468). Primary endpoints were ICU and hospital mortality and the acquisition of resistant bacteria. In the SDD group 69 (15%) patients died in the ICU compared with 107 (23%) in the control group (p=0.002). Hospital mortality was lower in the SDD groups than in the control group (113 [24%] vs 146 [31%], p=0.02). During their stay in intensive care, colonisation with gram-negative bacteria resistant to ceftazidime, ciprofloxacin, imipenem, polymyxin E, or tobramycin occurred in 61 (16%) of 378 SDD patients and in 104 (26%) of 395 patients in the control group (p=0.001). Colonisation with vancomycin-resistant enterococcus occurred in five (1%) SDD patients and in four (1%) controls (p=1.0). No patient in either group was colonised with meticillin-resistant Staphylococcus aureus. In a setting with low prevalence of vancomycin-resistant enterococcus and meticillin-resistant S aureus, SDD can decrease ICU and hospital mortality and colonisation with resistant gram-negative aerobic bacteria.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Global prospective epidemiologic and surveillance study of ventilator-associated pneumonia due to Pseudomonas aeruginosa.

              To estimate the prevalence of ventilator-associated pneumonia caused by Pseudomonas aeruginosa in patients at risk for ventilator-associated pneumonia and to describe risk factors for P. aeruginosa ventilator-associated pneumonia.
                Bookmark

                Author and article information

                Contributors
                massus@hotmail.es
                malato01@ucm.es
                beaafm@hotmail.com
                javier.hortal@yahho.es
                confocal@iisgm.es
                ebouza@microb.net
                +34- 91- 586 80 27 , mariaguembe@hotmail.com
                Journal
                BMC Infect Dis
                BMC Infect. Dis
                BMC Infectious Diseases
                BioMed Central (London )
                1471-2334
                4 December 2017
                4 December 2017
                2017
                : 17
                : 746
                Affiliations
                [1 ]ISNI 0000 0001 0277 7938, GRID grid.410526.4, Cardiac Surgery Postoperative Care Unit, , Hospital General Universitario Gregorio Marañón, ; Madrid, Spain
                [2 ]ISNI 0000 0001 0277 7938, GRID grid.410526.4, Instituto de Investigación Sanitaria Gregorio Marañón, ; Madrid, Spain
                [3 ]ISNI 0000 0000 9314 1427, GRID grid.413448.e, CIBER Enfermedades Respiratorias-CIBERES (CB06/06/0058), ; Madrid, Spain
                [4 ]ISNI 0000 0001 2157 7667, GRID grid.4795.f, Biology Department, School of Biology, , Universidad Complutense de Madrid, ; Madrid, Spain
                [5 ]ISNI 0000 0001 0277 7938, GRID grid.410526.4, Department of Clinical Microbiology and Infectious Diseases, , Hospital General Universitario Gregorio Marañón, ; Madrid, Spain
                [6 ]ISNI 0000 0001 0277 7938, GRID grid.410526.4, Confocal Laser Scanning Microscopy Unit, , Hospital General Universitario Gregorio Marañón, ; Madrid, Spain
                [7 ]ISNI 0000 0001 2157 7667, GRID grid.4795.f, Medicine Department, , School of Medicine, Universidad Complutense de Madrid, ; Madrid, Spain
                [8 ]ISNI 0000 0001 0277 7938, GRID grid.410526.4, Servicio de Microbiología Clínica y Enfermedades Infecciosas, , Hospital General Universitario “Gregorio Marañón”, ; C/. Dr. Esquerdo, 46, 28007 Madrid, Spain
                Author information
                http://orcid.org/0000-0002-7607-5848
                Article
                2856
                10.1186/s12879-017-2856-0
                5715999
                29202722
                f591c320-ff91-450d-8c75-c42c4d36a961
                © The Author(s). 2017

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 8 June 2017
                : 26 November 2017
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100004587, Instituto de Salud Carlos III;
                Award ID: CP13/00268
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100008433, Consejería de Educación, Juventud y Deporte, Comunidad de Madrid;
                Award ID: PEJ15/BIO/AI-0406
                Award Recipient :
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2017

                Infectious disease & Microbiology
                pseudomonas aeruginosa biofilm,ventilator-associated pneumonia,selective decontamination solution,lock therapy,confocal laser scanning microscopy

                Comments

                Comment on this article